The pharmaceutical packaging sector has seen an increased amount of interest in the last few years. With record numbers of attendees, exhibitors, and speakers at this year’s Pharmapack 2024, and several upcoming regulatory changes regarding packaging across all industries, it is clear that packaging innovation for the pharma industry is and will continue to be a priority.

For the pharma industry and supply chain, there are many factors to consider when it comes to packaging. One of the top priorities is sustainability, both through operations and materials. The health of the planet is intrinsically linked to human health and must be addressed as part of every business decision in pharmaceutical packaging. However, as with all pharmaceutical products, packaging experts must also consider patient safety, drug efficacy, and the ultimate cost of the above.

In our latest Trend Report, we uncover what it’s truly costing pharmaceutical packagers to consider the Triple Bottom Line of People, Planet, and Profit. With expert insight from the CiPPPA, Takeda Pharmaceuticals, the European Co-Packers Association, and more, this report explores how the pharmaceutical industry can balance the health of their business with the health of the people and planet.